{
    "2019-06-04": [
        [
            {
                "time": "2023-11-07",
                "original_text": "It's Official: bluebird bio Gets a Green Light for Game-Changing Gene Therapy",
                "features": {
                    "keywords": [
                        "bluebird bio",
                        "Green Light",
                        "Game-Changing",
                        "Gene Therapy"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2023-11-07",
                "original_text": "Aduro Stock Crashes After ASCO Updates on Cancer Candidate",
                "features": {
                    "keywords": [
                        "Aduro",
                        "Stock Crashes",
                        "ASCO Updates",
                        "Cancer Candidate"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2023-11-07",
                "original_text": "Long-term Survival Benefit Shown for Metastatic Melanoma Patients Treated with Novartis Tafinlar速 + Mekinist速",
                "features": {
                    "keywords": [
                        "Long-term Survival",
                        "Metastatic Melanoma",
                        "Novartis",
                        "Tafinlar速",
                        "Mekinist速"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}